Sexually Transmitted Diseases Testing Market Size Anticipated to Reach US$ 14.2 Billion by 2030, Driven by Growing Prevalence of STDs and Rising Awareness | According to RationalStat
November 14, 2023 02:00 ET
|
Rationalstat LLC
Wilmington, Delaware, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Global Sexually Transmitted Diseases Testing Market size is valued at US$ 8.5 billion in 2023 and is predicted to rise at a substantial CAGR...
Molecular Diagnostic for Infectious Diseases Market Size Worth $17.61 Billion, Globally, by 2030 - Exclusive Report by The Insight Partners
October 03, 2023 09:29 ET
|
The Insight Partners
Pune, India, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Molecular diagnostics is referred to as the detection of genomic variants, aiming to facilitate detection, diagnosis, subclassification, prognosis, and...
Male Condoms Market to Reach $13.97Bn by 2028 at 8% CAGR with Non-Latex Segment Driving Growth During 2022–2028 | The Insight Partners
July 04, 2023 08:21 ET
|
The Insight Partners
Pune, India, July 04, 2023 (GLOBE NEWSWIRE) -- According to Recently Published Report by The Insight Partners, “Male Condoms Market Size Report, Forecast to 2028 - COVID-19 Impact and Global...
HPV Vaccine Market: 5.73B by 2028, Human Papillomavirus Vaccine Market Growing at 5% CAGR Lead by 9-Valent HPV Vaccine Segment, Global Analysis by The Insight Partners
June 17, 2022 08:26 ET
|
The Insight Partners
New York, June 17, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Human Papillomavirus (HPV) Vaccine Market Size, Share, Growth, Revenue, Trends, Forecast to 2028...
Personal Lubricants Market Size ($2,933.62Mn by 2028) Lead by Water-Based Lubricant (10.9% CAGR) Impact of Coronavirus Outbreak and Global Analysis & Forecast by TheInsightPartners.com
October 29, 2021 12:47 ET
|
The Insight Partners
New York, Oct. 29, 2021 (GLOBE NEWSWIRE) -- Personal Lubricants Market: Key InsightsAccording to our new research study on Personal Lubricants Market Size and Forecast to 2028 - COVID-19 Impact and...
Earth Science Tech, Inc. Partners with Centre SIDA Amite Clinic to Commence Final Pre-Launch MSN-2 Human Research Study
October 10, 2017 08:30 ET
|
Earth Science Tech, Inc.
Doral, FL, Oct. 10, 2017 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC PINK: ETST) ("ETST" or "the Company"), an innovative biotech company that operates in the fields of hemp cannabinoid...
Earth Science Tech, Inc. Announces New Agreement with Axcelon Biopolymers Corp. for Distribution of Nanoderm™ Medical Device & Advances with Its MSN-2 Medical Device
September 19, 2017 08:45 ET
|
Earth Science Tech, Inc.
Doral, FL, Sept. 19, 2017 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC PINK: ETST) ("ETST" or "the Company"), an innovative biotech company that operates in the fields of hemp cannabinoid...
Earth Science Tech, Inc. Signs Contract with Absolu to Advance Phase-2 Rollout on MSN-2 Medical Device
August 03, 2017 08:35 ET
|
Earth Science Tech, Inc.
Hollywood, FL, Aug. 03, 2017 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC PINK: ETST) ("ETST" or "the Company"), an innovative biotech company that operates in the fields of hemp cannabinoid,...
Earth Science Tech, Inc. Launches Earth Science Pharmaceutical & MSN-2 Medical Device Websites, Adds Michel Gauthier M.D. to the Advisory Board, and Reports Over 80% Profit Increase
June 19, 2017 08:15 ET
|
Earth Science Tech, Inc.
Hollywood, June 19, 2017 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTCPINK: ETST), an innovative biotech company focused on cannabis CBD-based (industrial hemp), cannabinoid research and...
Earth Science Tech, Inc. Announces Timeline Projection for its MSN-2 Medical Device, and Partnership Negotiations for its Cannabis CBD-Based Generic Drugs & Medical Device Distribution
March 27, 2017 12:11 ET
|
Earth Science Tech, Inc.
Hollywood, March 27, 2017 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC PINK: ETST) ("ETST"), an innovative biotech company focused on cannabis (industrial hemp) and cannabinoid research and...